Profound Medical Corp reports results for the quarter ended December 31 - Earnings Summary
07/03/2025 01:34
Profound Medical Corp PRN.TO reported a quarterly adjusted loss of 20 cents per share for the quarter ended December 31, higher than the same quarter last year, when the company reported EPS of -42 cents. The mean expectation of three analysts for the quarter was for a loss of 35 cents per share. Wall Street expected results to range from -39 cents to -30 cents per share. Revenue rose 107.9% to $4.18 million from a year ago; analysts expected $4.27 million. Profound Medical Corp's reported EPS for the quarter was a loss of 20 cents. The company reported a quarterly loss of $4.95 million. Profound Medical Corp shares had fallen by 4.6% this quarter. FORECAST CHANGES The mean earnings estimate of analysts had risen by about 2.8% in the last three months. In the last 30 days, one analyst negatively revised an earnings estimate RECOMMENDATIONS The current average analyst rating on the shares is "strong buy" and the breakdown of recommendations is 2 "strong buy" or "buy," no "hold" and no "sell" or "strong sell." The average consensus recommendation for the advanced medical equipment & technology peer group is "buy." Wall Street's median 12-month price target for Profound Medical Corp is C$24.42 This summary was machine generated from LSEG data March 7 at 01:33 a.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
| QUARTER ENDING | ESTIMATE | ACTUAL | BEAT, MET, MISSED |
| Dec. 31 2024 | -0.35 | -0.20 | Beat |
| Sep. 30 2024 | -0.29 | -0.38 | Missed |
| Jun. 30 2024 | -0.29 | -0.28 | Beat |
| Mar. 31 2024 | -0.27 | -0.26 | Beat |